European Association of Urology guidelines on non–muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)
M Babjuk, M Burger, O Capoun, D Cohen… - European urology, 2022 - Elsevier
Abstract Context The European Association of Urology (EAU) has released an updated
version of the guidelines on non–muscle-invasive bladder cancer (NMIBC). Objective To …
version of the guidelines on non–muscle-invasive bladder cancer (NMIBC). Objective To …
Bladder cancer: a review
AT Lenis, PM Lec, K Chamie, MD Mshs - Jama, 2020 - jamanetwork.com
Importance Bladder cancer is a common malignancy in women and is the fourth most
common malignancy in men. Bladder cancer ranges from unaggressive and usually …
common malignancy in men. Bladder cancer ranges from unaggressive and usually …
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
T Powles, J Bellmunt, E Comperat… - Annals of …, 2022 - annalsofoncology.org
Urothelial carcinoma (UC), also described as bladder cancer, is the 10th most common
cancer type worldwide, with an estimated 549 000 new cases and 200 000 deaths in 2018 …
cancer type worldwide, with an estimated 549 000 new cases and 200 000 deaths in 2018 …
European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-2019 update
M Babjuk, M Burger, EM Compérat, P Gontero… - European urology, 2019 - Elsevier
Context This overview presents the updated European Association of Urology (EAU)
guidelines for non–muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ …
guidelines for non–muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ …
Recurrence mechanisms of non-muscle-invasive bladder cancer—A clinical perspective
Non-muscle-invasive bladder cancer (NMIBC) is an early-stage cancer without invasion into
the detrusor muscle layer. Transurethral resection of bladder tumour (TURBT) is a diagnostic …
the detrusor muscle layer. Transurethral resection of bladder tumour (TURBT) is a diagnostic …
European association of Urology guidelines on non–muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ)—A summary of the 2024 guidelines update
P Gontero, A Birtle, O Capoun, E Compérat… - European Urology, 2024 - Elsevier
Background and objective This publication represents a summary of the updated 2024
European Association of Urology (EAU) guidelines for non–muscle-invasive bladder cancer …
European Association of Urology (EAU) guidelines for non–muscle-invasive bladder cancer …
Magnetic‐Powered Janus Cell Robots Loaded with Oncolytic Adenovirus for Active and Targeted Virotherapy of Bladder Cancer
A unique robotic medical platform is designed by utilizing cell robots as the active “Trojan
horse” of oncolytic adenovirus (OA), capable of tumor‐selective binding and killing. The OA …
horse” of oncolytic adenovirus (OA), capable of tumor‐selective binding and killing. The OA …
Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic
Context The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …
Prospective assessment of vesical imaging reporting and data system (VI-RADS) and its clinical impact on the management of high-risk non–muscle-invasive bladder …
F Del Giudice, G Barchetti, E De Berardinis… - European urology, 2020 - Elsevier
Abstract Background Vesical Imaging Reporting and Data System (VI-RADS) score is
adopted to provide preoperative bladder cancer (BCa) staging. Repeated transurethral …
adopted to provide preoperative bladder cancer (BCa) staging. Repeated transurethral …
Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: results from the randomized controlled BRAVO-feasibility …
PURPOSE High-grade nonmuscle invasive bladder cancer (HRNMIBC) is a heterogeneous
disease. Treatments include intravesical maintenance Bacillus Calmette-Guerin (mBCG) …
disease. Treatments include intravesical maintenance Bacillus Calmette-Guerin (mBCG) …